Shariah compliance overview
HalalNeuroPace, Inc. (NPCE) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About NeuroPace, Inc.
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy.
NeuroPace, Inc. (NPCE) operates in the Healthcare sector, in the Medical - Devices industry.
Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 2.74% (limit 5%), interest-bearing debt is 17.25% (limit 30%) and interest-bearing securities and assets are 17.27% (limit 30%).
If you hold NPCE, give 2.74% of the dividends you receive to charity to purify the non-compliant share of its income.
- Business Activity
- 2.74%Limit 5%Pass
- Interest-bearing debt
- 17.25%Limit 30%Pass
- Interest-bearing securities and assets
- 17.27%Limit 30%Pass
- Dividend purification
- 2.74%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about NeuroPace, Inc. (NPCE). Current Akinda screening label: Halal.
